UBS Upgrades Chemours and Raises Target Price in Bullish Move
Tuesday, 9 July 2024, 10:01
UBS upgrades Chemours to Buy, raises target to $30
UBS has upgraded Chemours to Buy and raised the target price to $30, indicating a bullish stance on the company's performance. This move suggests confidence in Chemours' future potential and may attract investor interest.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.